DOPRAM
Details
- Status
- Prescription
- First Approved
- 1965-06-23
- Routes
- INJECTION
- Dosage Forms
- INJECTABLE
DOPRAM Approval History
What DOPRAM Treats
6 indicationsDOPRAM is approved for 6 conditions since its original approval in 1965. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Postanesthesia Respiratory Depression
- Apnea
- Drug-Induced Central Nervous System Depression
- Chronic Obstructive Pulmonary Disease
- Acute Respiratory Insufficiency
- Acute Hypercapnia
Drugs Similar to DOPRAM
FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
DOPRAM FDA Label Details
ProIndications & Usage
FDA Label (PDF)Postanesthesia When the possibility of airway obstruction and/or hypoxia have been eliminated, doxapram may be used to stimulate respiration in patients with drug-induced postanesthesia respiratory depression or apnea other than that due to muscle relaxant drugs. To pharmacologically stimulate deep breathing in the postoperative patient. (A quantitative method of assessing oxygenation, such as pulse oximetry, is recommended.) Drug-Induced Central Nervous System Depression Exercising care to prevent vomiting and aspiration, doxapram may be used to stimulate respiration, hasten arousal, and to e...
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.